ATLASAnnovis Bio (ANVS) earnings date: Nov 11, 2026
Annovis Bio (ANVS) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026. Analysts expect EPS of -$0.30.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ANVS
| Last price | $1.09 (-3.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.6% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Annovis Bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Annovis Bio reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Annovis Bio. You can switch it off at any time.
Alert me before ANVS reportsFree to start. Creating an account takes under a minute.
Notify me when Annovis Bio reports
Track ANVS free Add Annovis Bio to a free ATLAS watchlist and see its next report date in one place.
ANVS earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.30 |
| Last report | Aug 14, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -16.9% |
| Average move around a report | ±6.5% (last 5) |
| Sector | Healthcare · Biotechnology |
Annovis Bio earnings history: last 5 reports
Annovis Bio last reported on Aug 14, 2026: EPS of -$0.40 against an estimate of -$0.46 (+13.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.46 | -$0.40 | +13.0% | Beat | -2.8% |
| May 15, 2026 | -$0.35 | -$0.63 | -80.0% | Miss | -3.8% |
| Apr 10, 2026 | -$0.16 | -$0.14 | +12.5% | Beat | +2.5% |
| Mar 13, 2026 | -$0.30 | -$0.39 | -30.0% | Miss | +15.0% |
| Nov 12, 2025 | -$0.37 | -$0.37 | 0.0% | In line | +8.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ANVS
See the fair value, the probability range and the earnings history of Annovis Bio on its ATLAS page.
Annovis Bio (ANVS) stock analysisPlans from €3.99 a month.
Annovis Bio earnings: frequently asked questions
When does Annovis Bio (ANVS) report earnings?
Annovis Bio is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ANVS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.30 per share (USD). Estimates can change before the report.
How often does ANVS beat earnings estimates?
Of its last 5 reports with a recorded result, Annovis Bio beat the EPS estimate 2 times; the average surprise was -16.9%. Past results do not predict the next one.
How much does ANVS move around earnings?
Over its last 5 reports the stock moved an average of 6.5% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Annovis Bio beat earnings estimates last quarter?
Annovis Bio last reported on Aug 14, 2026: EPS of -$0.40 against an estimate of -$0.46 (+13.0% surprise), a beat.
How much does ANVS usually move in a day?
On a normal trading day the ATLAS model puts ANVS’s one-day range at about ±4.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer